tirzepatide en polvo FDA confirms shortage is still over, gives compounders a grace period Buy Tirzepatide (60 mg) |

Hims & Hers raised its full-year 2026 revenue guidance to a range of $2.8 billion to $3 billion, representing growth of 19% to 28% from 2025 levels, and updated adjusted EBITDA guidance to a range of $275 million to $350 million.

Animals were allocated to groups according to body weight (BW)

Sobo, patients can discuss weight-loss goals in a clinical setting where the emphasis is on health, not hype

Effects of GEP44 and GEP12 on islets and muscle are mediated by both GLP-1R and Y1-R Insulin secretion from rat and human islets was measured in the presence of 20 mM glucose and the presence or absence of various test compounds using both static and perifusion analyses